clinical trials
- Technology
Musk’s brain implant company ‘Neuralink’ nears human trials
San Francisco: Elon Musk-run brain-machine interface company Neuralink is preparing to launch clinical trials that will implant brain chips in humans. According to dailymail.co.uk, the firm is hiring a clinical trial director,…
- Hyderabad
IVI, Bharat Biotech begin phase II/III clinical trial of Chikungunya vaccine
Hyderabad: The International Vaccine Institute (IVI) and Bharat Biotech on Wednesday announced the beginning of Phase II/III clinical trial of Chikungunya vaccine candidate (BBV87) in Costa Rica. IVI is leading the Global…
- India
India’s first mRNA vaccine phase-I clinical trial gets nod
New Delhi: The Central Drugs Standard Control Organisation (CDSCO), India’s National Regulatory Authority, has approved Gennova Biopharmaceuticals Limited’s work on the country’s first mRNA-based COVID-19 vaccine for its clinical data of the phase-1…
- India
COVAXIN trial results on children likely by September: AIIMS chief
New Delhi: Trials for Bharat Biotech’s Covid-19 vaccine Covaxin on children are underway and results are expected to be released by September, All India Institute of Medical Sciences (AIIMS) director Randeep Guleria…
- World
Brazil suspends Bharat Biotech’s Covaxin clinical trials
Hyderabad: Brazil has suspended the clinical studies of Bharat Biotech’s COVID-19 vaccine, Covaxin following termination of the company’s agreement with its partner there, the South American Country’s health regulator said. Bharat Biotech…
- World
SII partner Novavax’s COVID-19 shot 90% effective
Washington: US-based biotechnology company Novavax’s protein-based vaccine has shown overall 90 per cent efficacy against Covid-19, results of Phase-3 trials have shown. The vaccine NVX-CoV2373 is already being locally manufactured by the company’s…
- India
CSIR to start clinical trials of Colchicine vaccine on COVID patients
New Delhi: The Council of Scientific and Industrial Research (CSIR) will undertake a two-arm phase-II clinical trial to assess the safety and efficacy of the drug Colchicine for the treatment of Covid-19 patients.…
- India
Took Covaxin jab? Your international travel plans may be hampered
New Delhi: As several countries get ready to reopen their borders for vaccinated foreign travellers, Indians who have received Bharat Biotech’s Covid-19 vaccine Covaxin jabs may not qualify for travelling abroad as many…
- Hyderabad
Bharat Biotech gets DCGI nod to 2-18 age group clinical trials
Hyderabad: In a significant development to tackle rising corona cases, the Centre has accorded permission to the Bharat Biotech company of Hyderabad to conduct clinical trials to offer its injections to those…
- India
As India pushes for clinical trials, Pfizer reassures on safety of its vaccine
New Delhi: Pfizer pharmaceutical company on Monday said that it informed the Indian government that there are zero concerns over the safety of its COVID-19 vaccine, as the latter insists on holding…
- India
Biological E to begin phase 3 trials for COVID-19 vaccine
Hyderabad: Hyderabad-based vaccine and pharmaceutical company Biological E. Limited (BE) today announced that it has successfully completed the phase I/II clinical trials of its COVID-19 subunit vaccine candidate in India. The company…
- India
Bharat Biotech finds Covaxin 81pc efficient in Phase 3 trials
New Delhi: Bharat Biotech on Wednesday said its COVID-19 vaccine Covaxin has demonstrated an interim vaccine efficacy of 81 per cent in Phase 3 clinical trials. The process involved 25,800 subjects, the largest…
- Middle East
Saudi Arabia begins first phase of its COVID vaccine clinical trails
Jeddah: Saudi Arabia on Tuesday started the first phase of its COVID-19 vaccine clinical trials at Saudi Arabia’s Imam Abdul Rahman bin Faisal University. The vaccine will only be used for inoculation…
- World
Pfizer, BioNTech start late-stage clinical trial of COVID vax
New York: US-based Pfizer and German biotech firm BioNTech have announced the start of a late-stage clinical trial of a COVID-19 vaccine jointly developed by the two companies. The Phase 2/3 study will…
- Hyderabad
NIMS to begin human clinical trials of COVID vaccine from tomorrow
Hyderabad: Nizam’s Institute of Medical Sciences (NIMS) has been chosen for conducting human clinical trials of COVID vaccine which will begin from Tuesday (July 7). Indian Council of Medical Research (ICMR) has…
- 1
- 2